Alan List - 03 Mar 2023 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Medical Officer
Signature: /s/ Dario Scimeca, Attorney-in-Fact for Alan List
Issuer symbol: DTIL
Transactions as of: 03 Mar 2023
Net transactions value: -$10,136
Form type: 4
Filing time: 07 Mar 2023, 16:16:16 UTC
Previous filing: 24 Jan 2023
Next filing: 28 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Options Exercise		+29,453	+161%		47,713	03 Mar 2023	Direct	F1, F2
transaction	DTIL	Common Stock	Sale	$10,136	-9,473	-20%	$1.07	38,240	06 Mar 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Options Exercise	$0	+29,453	+100%	$0.000000	58,890	03 Mar 2023	Common Stock	29,453		Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023.
F2	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3	The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4	On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.